← Leaderboards
Daniel Bochar
Cayman Chemical Company, Inc.
$224,852
Attributed
$224,852
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$224,852 · 1
By mechanism
R41$224,852 · 1
Top collaborators
No co-investigators on record.
Most similar at Cayman Chemical Company, Inc.
Same institution · by research overlap
- Stephen Douglas Barrett$1,478,369
- Thomas A Owen$850,243
- Paul Douglas Kennedy$306,868
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposAssay DevelopmentCognitionAnimal ModelCaymansBaseBenzodiazepinesBiochemicalBrainCaringEnvironmental Risk FactorCell ModelCellsChronic Brain DamageAmericanCollectionCytotoxicDendritesDensityDepositionDrug PrescriptionsEnvironmental HealthAffectAbnormally Phosphorylated Tau